Alcon Falls as Mixed Q3 Results and Tighter Outlook Pressure Shares

Alcon (ALC) is down 4.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears tied to Alcon’s third-quarter update, which paired an earnings beat with softer revenue quality and a more cautious full-year outlook. Investors seem focused on weaker implantables demand, competitive pressure in premium intraocular lenses, and lower market growth assumptions rather than the headline profit figure.

Details:

Alcon reported third-quarter 2026 sales of $2.7 billion, up 5% year over year, with core diluted EPS of $0.91.

The company tightened its 2026 outlook to about 6% constant-currency sales growth, narrowed its core operating margin expansion range to 100 to 150 basis points, and trimmed the top end of its core EPS growth range to 12% to 14%.

Management said aggregate end markets are now expected to grow about 3% this year, and also flagged specific areas of competitive pressure.

Implantables sales fell 2% in the quarter, with weakness tied to the U.S. premium intraocular lens category and reimbursement pressure in certain procedures, which likely added to concerns about Alcon’s forward growth path.

Sources:

Alcon Investor Relations, SEC, MarketScreener

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$ALC Hedge Fund Activity

We have seen 229 institutional investors add shares of $ALC stock to their portfolio, and 393 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

INVESCO LTD. added 10,020,691 shares (+2786.3%) to their portfolio in Q2 2026, for an estimated $672,388,366
FRANKLIN RESOURCES INC removed 3,464,603 shares (-80.7%) from their portfolio in Q2 2026, for an estimated $232,474,861
BANK OF NEW YORK MELLON CORP removed 2,921,037 shares (-22.4%) from their portfolio in Q3 2026, for an estimated $189,137,145
CANTILLON CAPITAL MANAGEMENT LLC removed 2,507,095 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $168,226,074
LBP AM SA added 2,414,092 shares (+inf%) to their portfolio in Q3 2026, for an estimated $156,312,457
JPMORGAN CHASE & CO added 2,221,073 shares (+inf%) to their portfolio in Q2 2026, for an estimated $149,033,998
TROY ASSET MANAGEMENT LTD removed 2,085,169 shares (-54.9%) from their portfolio in Q3 2026, for an estimated $135,014,692

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$ALC Congressional Stock Trading

Members of Congress have traded $ALC stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $ALC stock by members of Congress over the last 6 months:

REPRESENTATIVE KEVIN HERN sold up to $15,000 on 08/05.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.